Osteomalacia oncogénica secundaria a tumor mesenquimal fosfatúrico del pie

Chong, 2011, Tumor-induced osteomalacia, Endocr Relat Cancer., 18, R53, 10.1530/ERC-11-0006 Jiang, 2012, Tumor-induced osteomalacia: An important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature, J Bone Miner Res., 27, 1967, 10.1002/jbmr.1642 Yu, 2017, Reports of 17 Chinese patients with tumor-induced osteomalacia, J Bone Miner Metab., 35, 298, 10.1007/s00774-016-0756-9 Martin, 2012, Regulation and function of the FGF23/klotho endocrine pathways, Physiol Rev., 92, 131, 10.1152/physrev.00002.2011 Hautmann, 2015, Tumor-induced osteomalacia: An up-to-date review, Curr Rheumatol Rep., 17, 512, 10.1007/s11926-015-0512-5 Bishay, 2017, Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: A report of two cases and review of the literature, Ther Adv Endocrinol Metab., 14, 10.1177/2042018816678363 Earle, 2004, Fanconi's syndrome in HIV+adults: Report of three cases and literature review, J Bone Miner Res., 19, 714, 10.1359/jbmr.2004.19.5.714 Folpe, 2004, Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature, Am J Surg Pathol., 28, 1, 10.1097/00000478-200401000-00001 Weidner, 1991, Review and update: Oncogenic osteomalacia-rickets, Ultrastruct Pathol., 15, 317, 10.3109/01913129109016242 Qiu, 2017, Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report, Medicine (Baltimore)., 96, pe6750, 10.1097/MD.0000000000006750 Chong, 2011, The importance of whole body imaging in tumor-induced osteomalacia, J Clin Endocrinol Metab., 96, 3599, 10.1210/jc.2011-1757 Duet, 2008, Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia, Clin Nucl Med., 33, 752, 10.1097/RLU.0b013e31818866bf Fukumoto, 2004, Diagnostic modalities for FGF23-producing tumors in patients with tumor-induced osteomalacia, Endocrinol Metab (Seoul)., 29, 136, 10.3803/EnM.2014.29.2.136 Ogura, 2008, Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23, Intern Med., 47, 637, 10.2169/internalmedicine.47.0761 Sun, 2015, Surgical treatment of tumor-induced osteomalacia: A retrospective review of 40 cases with extremity tumors, BMC Musculoskelet Disord., 16, 10.1186/s12891-015-0496-3 Hesse, 2007, Radiofrequency ablation of a tumor causing oncogenic osteomalacia, N Engl J Med., 357, 422, 10.1056/NEJMc070347 Seufert, 2001, Octreotide therapy for tumor-induced osteomalacia, N Engl J Med., 345, 1883, 10.1056/NEJMoa010839 Imel, 2015, Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23, J Clin Endocrinol Metab., 100, 2565, 10.1210/jc.2015-1551